These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3286291)

  • 1. Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome.
    Eshel A; Abdulwahid NA; Armar NA; Adams JM; Jacobs HS
    Fertil Steril; 1988 Jun; 49(6):956-60. PubMed ID: 3286291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results.
    Burger CW; Hompes PG; Korsen TJ; Schoemaker J
    Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.
    Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J
    Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS; Seibel MM
    J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL; Farhi J; Homburg R; Jacobs HS
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary response during pulsatile luteinizing hormone-releasing hormone ovulation--induction in patients with clomiphene citrate-resistant polycystic ovary-like disease.
    Burger CW; Korsen TJ; Schoemaker J
    Gynecol Endocrinol; 1988 Mar; 2(1):19-33. PubMed ID: 3140589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.
    Timmerman-van Kessel EC; Cikot RJ; Dargel-Donkers EJ; Zwertbroek W; van Dop PA; Schoot DC
    Fertil Steril; 2000 Jun; 73(6):1145-8. PubMed ID: 10856472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ovulation in long-standing secondary amenorrhea with clomiphene citrate and repeated injections of LH-RH. Preliminary report.
    Casas F; Turner D; Badano A; Mirkin A; Miechi H; Aparicio NJ; Pedroza E; Laborde N; Rosner J
    Reproduccion; 1976; 3(1-2):141-8. PubMed ID: 800387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of timed ovulation with synthetic luteinizing hormone-releasing hormone in women undergoing insemination therapy. I. Effect of a single parenteral administration at midcycle.
    Grimes EM; Taymor ML; Thompson IE
    Fertil Steril; 1975 Mar; 26(3):277-82. PubMed ID: 1090455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of ovulation by prolonged pulsatile administration of luteinizing hormone releasing hormone (LRH) in patients with clomiphene resistant polycystic ovary-like disease.
    Burger CW; van Kessel H; Schoemaker J
    Acta Endocrinol (Copenh); 1983 Nov; 104(3):357-64. PubMed ID: 6415997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
    Corenthal L; Von Hagen S; Larkins D; Ibrahim J; Santoro N
    Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile luteinizing hormone secretion in women with polycystic ovary syndrome under clomiphene citrate. Differences between responders and nonresponders.
    Sir-Petermann T; Alba F; Cohen P; Pacheco J; Devoto L; Rossmanith W
    Exp Clin Endocrinol; 1990 Sep; 96(1):45-51. PubMed ID: 2126241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ovulation with clomiphene citrate followed by LH-RH in women.
    Maia H; Barbosa IC; Maia H; Hirsch C; Tironi E; Coutinho EM
    Int J Gynaecol Obstet; 1983 Feb; 21(1):1-6. PubMed ID: 6133787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ovulation with pulsatile gonadotropin releasing hormone (GnRH) in anovulatory women.
    Cignitti M; Mazzarini A; Pini A; Garzetti GG; Romanini C
    Acta Eur Fertil; 1990; 21(5):235-8. PubMed ID: 2132474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of gonadoliberin (follicle-stimulating hormone/luteinizing hormone-releasing hormone) in women.
    Zárate A; Canales ES; Soria J; Forsbach G; Kastin AJ; Schally AV
    Fertil Steril; 1976 Nov; 27(11):1233-9. PubMed ID: 824160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical aspects of pulsatile gonadotropin-releasing hormone administration.
    Schriock ED
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1765-70. PubMed ID: 2240131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.